JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ku, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ku, D. D.

Unmasking of thrombin vasoconstriction in isolated perfused dog hearts after intracoronary infusion of air embolus

DD Ku

Department of Pharmacology, University of Alabama at Birmingham.

Effects of intracoronary thrombin and acetylcholine administration on coronary vascular reactivity were studied in isolated perfused (Langendorff) dog hearts before and after air embolus treatment. Under constant flow condition with control coronary perfusion pressure of 71.4 +/- 5.4 mm Hg (mean +/- S.E.M. of eight hearts), infusion of thrombin (0.1 U/ml) resulted in an immediate decrease (-32.8 +/- 2.7 mm Hg) in coronary perfusion pressure, reaching a maximum in approximately 20 to 25 sec. Similar vasodilatory response (-30.5 +/- 1.9 mm Hg, M +/- S.E.M. of six hearts) also was observed with administration of 0.1 microM acetylcholine. Introduction of 0.3 ml air embolus into the coronary circulation before thrombin or acetylcholine testings, however, showed a 100 and 63% decrease in their respective coronary vasodilatory responses. More importantly, infusion of thrombin into these previously air embolus-treated hearts actually resulted in a potent vasoconstriction by increasing the coronary perfusion pressure (+48.2 +/- 5.7 mm Hg, mean +/- S.E.M. of six hearts) above the control level. The coronary vasoconstrictory effect of thrombin was reversible upon cessation of thrombin infusion or with concurrent administration of sodium nitroprusside (1 microM). Similarly, synthetic thrombin inhibitor phenylalanyl-prolyl-arginine chloromethyl ketone (0.1 microM) also was capable of both inhibiting and reversing thrombin-induced vasoconstriction. The present finding of a potent thrombin-induced coronary vasoconstriction in intact hearts after air embolus infusion further supports the hypothesis that an activation of thrombin in certain pathological states with injured endothelium may have an important role in the genesis of coronary vasospasm.

Volume 243, Issue 2, pp. 571-576, 11/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1987 by the American Society for Pharmacology and Experimental Therapeutics.